Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers
- Status
- TERMINATED
- Phase
- PHASE1
T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge
- Status
- COMPLETED
- Phase
- NA
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pozelimab in Combination With Cemdisiran in Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)
- Status
- WITHDRAWN
- Phase
- PHASE3
Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment
- Status
- COMPLETED
- Phase
- PHASE2
An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis
- Status
- UNKNOWN
- Phase
- PHASE4
Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19
- Status
- COMPLETED
- Phase
- PHASE1
Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Assess the Safety, Tolerability, and Pharmacokinetics of REGN5381 (an NPR1 Agonist) in Adult Humans
- Status
- COMPLETED
- Phase
- PHASE1
Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE4
Study of a Single Subcutaneous Dose of Pozelimab Produced From Two Different Manufacturing Processes in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation
- Status
- COMPLETED
- Phase
- PHASE3
COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay
- Status
- COMPLETED
- Phase
- PHASE3